Drawing for SION

USPTO serial 99327850

SION

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
Examiner
KRASS,KRISTINA M
Law office
TMO LAW OFFICE 115

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith Toms, Esq.

Keith Toms, Esq. McCarter & English265 Franklin StreetBoston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations; Pharmaceutical preparations for the treatment of Cystic Fibrosis; Pharmaceutical preparations for the treatment of genetic diseases or disorders; Pharmaceutical preparations for the treatment of endocrine diseases or disorders; Pharmaceutical preparations for the treatment of pulmonary, respiratory, gastrointestinal, digestive, metabolic, and pancreatic diseases or disordersACTIVE
042Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Testing of pharmaceuticals; Consulting services for others in the field of pharmaceutical research and development; Consulting services for others in the field of pharmaceuticals; Research and development in the field of Cystic Fibrosis; Research and development in the field of genetic diseases or disorders; Research and development in the field of endocrine diseases or disorders; Research and development in the field of pulmonary, respiratory, gastrointestinal, digestive, metabolic, and pancreatic diseases or disordersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 30, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 30, 2026GNSLLETTER OF SUSPENSION E-MAILED
Jul 30, 2026CNSLSUSPENSION LETTER WRITTEN
Jun 23, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 23, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 23, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 22, 2025DOCKASSIGNED TO EXAMINER
Dec 18, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Aug 8, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance